Clinical Trial Update: A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants

View source ↗

Summary

This study assesses persistence of guselkumab treatment in psoriatic arthritis; the trial is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Arthritis, Psoriatic | Status: NOT_YET_RECRUITING